Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Disease; Flu”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00389857
What this trial is testing

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 31
Post-approval studies (Phase 4)Study completedNCT00311428
What this trial is testing

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Who this might be right for
Influenza
Novartis 270
Not applicableStudy completedNCT06088563
What this trial is testing

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Kidney Transplant Recipients -ChronoVAX

Who this might be right for
Vaccination; Infection
Centre Hospitalier Universitaire de Nice 38
Not applicableStudy completedNCT00296270
What this trial is testing

Memory for Flu Facts and Myths and Effects on Vaccine Intentions

Who this might be right for
Influenza Vaccines
University of Michigan 175
Not applicableStudy completedNCT01024673
What this trial is testing

Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)

Who this might be right for
Influenza
University of Pittsburgh 38
Large-scale testing (Phase 3)Study completedNCT03139565
What this trial is testing

High Dose vs. Standard Influenza Vaccine in Adult SOT

Who this might be right for
InfluenzaImmunosuppression
University Health Network, Toronto 172
Not applicableStudy completedNCT01304563
What this trial is testing

2010/2011 Trivalent Influenza Vaccination

Who this might be right for
Influenza
The University of Hong Kong 240
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00316628
What this trial is testing

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Who this might be right for
Influenza
Novartis 50
Not applicableStudy completedNCT02401893
What this trial is testing

Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults

Who this might be right for
Aging
Vanderbilt University 510
Large-scale testing (Phase 3)Study completedNCT04537234
What this trial is testing

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 165
Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Testing effectiveness (Phase 2)Study completedNCT00336453
What this trial is testing

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

Who this might be right for
Influenza
Protein Sciences Corporation 156
Not applicableLooking for participantsNCT06643039
What this trial is testing

Nosocomial Respiratory Virus Infection

Who this might be right for
Nosocomial Infections
Hospices Civils de Lyon 1,000
Not applicableStudy completedNCT05163730
What this trial is testing

Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel

Who this might be right for
COVID-19Influenza AInfluenza Type B
Abbott Rapid Diagnostics Jena GmbH 2,472
Testing effectiveness (Phase 2)Study completedNCT00623181
What this trial is testing

Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 110
Not applicableStudy completedNCT03278067
What this trial is testing

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

Who this might be right for
Influenza, Human
GlaxoSmithKline 23,939
Not applicableUnknownNCT02996136
What this trial is testing

Assessment of the Clinical Performance of the ARROW-FLU System

Who this might be right for
Influenza, Human
Sekisui Diagnostics, LLC 3,000
Large-scale testing (Phase 3)Study completedNCT01229371
What this trial is testing

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

Who this might be right for
Influenza
Crucell Holland BV 440
Not applicableStudy completedNCT05234229
What this trial is testing

Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers

Who this might be right for
Pertussis/Whooping CoughInfluenza Viral Infections
Central Hospital, Nancy, France 254
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation